Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...

Cushings Syndrome Market: Growth Analysis and Competitive Analysis

High blood pressure, abdominal obesity, a round red face, a fatty mass between the shoulders, weak muscles and bones, acne, brittle skin, and other symptoms are all signs of Cushing's syndrome. Pituitary adenoma and multiple endocrine neoplasia are the most common causes of Cushing's syndrome.

Intake of glucocorticoids recommended by a healthcare professional to treat other disorders such as asthma, rheumatoid arthritis, or immunosuppression following an organ transplant is the most common cause of Cushing's syndrome. The disease can also be caused by the use of synthetic ACTH. Other animals, such as cats, dogs, and horses, may also be affected. All of the aforementioned causes are projected to boost the Cushings syndrome Market.


Cushings Syndrome Market
Crushings Syndrome Market


Cushing's syndrome, also known as hypercortisolism, is a hormonal condition characterised by continuous exposure of bodily tissue to excessive quantities of the hormone cortisol. Cushing's syndrome affects adults between the ages of 20 and 50. It is uncommon, however it is at risk of developing in obese patients with type 2 diabetes, high blood pressure, and poorly regulated blood glucose. The Cushing's syndrome Market is expected to grow due to increased awareness and healthcare spending. Various new medications, such as ketoconazole, metyrapone, and mitotane, are now available on the market as a result of increased research and development to reduce the surgical risk of patients. Cushing's syndrome is expected to have a yearly incidence of 1–3 cases per million inhabitants, according to the Orphanet Journal of Rare Disease, but its frequency was close to 40 cases per million inhabitants in 2012.

Furthermore, factors contributing to the market's growth include an unhealthy lifestyle, an increase in the geriatric population, and steroid usage. Difficulties in diagnosis, a lack of pipeline products, and rigorous restrictions, among other things, are limiting the global Cushing's syndrome market's growth.

 

Market for Cushing's Syndrome: A Competitive Analysis

Increased research and development in 2016, like Strongbrigde Biopharma plc's development of clinical trials for RECORLEV for the treatment of endogenous Cushing's syndrome, is expected to increase competition and favour growth among manufacturers to lead the market. Corcept Therapeutics Inc., HRA Pharma, Strongbridge Biopharma plc., and Novartis AG are among the leading companies in the Cushing's syndrome industry.

Comments

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Malaria Vaccines Market – Making Way for a Malaria-Free World

Global and China Catheter Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027